Horizon Kinetics Medical ETF (MEDX)
NASDAQ: MEDX · Real-Time Price · USD
34.31
+0.04 (0.12%)
Feb 11, 2026, 1:39 PM EST - Market open
MEDX Holdings Information
MEDX is an equity ETF with a total of 34 individual holdings. The top holdings are Eli Lilly and Company stock at 17.13%, AbbVie at 8.37%, Novartis AG ADR at 7.36%, US BANK MMDA - USBGFS 7 at 7.18%, and Johnson & Johnson at 5.60%.
Total Holdings
34
Top 10 Percentage
69.29%
Asset Class
Equity
ETF Category
Health
Assets
19.82M
PE Ratio
22.97
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 17.13% |
| 2 | ABBV | AbbVie Inc. | 8.37% |
| 3 | NVSN.MX | Novartis AG ADR | 7.36% |
| 4 | n/a | US BANK MMDA - USBGFS 7 | 7.18% |
| 5 | JNJ | Johnson & Johnson | 5.60% |
| 6 | LON: AZN | AstraZeneca PLC | 5.27% |
| 7 | IONS | Ionis Pharmaceuticals, Inc. | 5.16% |
| 8 | BMY | Bristol-Myers Squibb Company | 4.97% |
| 9 | AMGN | Amgen Inc. | 4.33% |
| 10 | ALKS | Alkermes plc | 3.92% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.87% |
| 12 | MRK | Merck & Co., Inc. | 3.86% |
| 13 | PFE | Pfizer Inc. | 3.42% |
| 14 | GSK | GSK plc | 3.25% |
| 15 | BIIB | Biogen Inc. | 2.95% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 2.74% |
| 17 | CRSP | CRISPR Therapeutics AG | 2.56% |
| 18 | BEAM | Beam Therapeutics Inc. | 1.28% |
| 19 | VNDA | Vanda Pharmaceuticals Inc. | 0.95% |
| 20 | NTLA | Intellia Therapeutics, Inc. | 0.88% |
| 21 | SDZNY | Sandoz Group AG | 0.77% |
| 22 | HLN | Haleon plc | 0.75% |
| 23 | GALT | Galectin Therapeutics Inc. | 0.71% |
| 24 | REPL | Replimune Group, Inc. | 0.55% |
| 25 | BCYC | Bicycle Therapeutics plc | 0.41% |
As of Feb 9, 2026